Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New history entries document additional study record updates (e.g., recruitment status and contacts/locations) on the Record History page. The overall page layout remains unchanged.
    Difference
    0.1%
    Check dated 2025-11-03T09:53:33.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Added a government operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    9%
    Check dated 2025-10-05T14:35:22.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T09:48:42.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. No other substantive content changes.
    Difference
    0.5%
    Check dated 2025-09-14T00:18:17.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.5%
    Check dated 2025-09-06T21:13:17.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of study locations.
    Difference
    49%
    Check dated 2025-08-30T15:36:11.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.